Dr Shipra Gandhi

Updates from ASCO23: X-7/7 Trial

X-7/7 trial: Alternative fixed dosing of capecitabine associated with similar efficacy with better safety profile   By Drs. Arya Mariam…

2 years ago

Updates from ASCO2023 – The SONIA Trial

By Dr. Arya Miriam Roy & Dr. Shipra Gandhi of Roswell Park Comprehensive Cancer Center   The CDK 4/6 inhibitors…

2 years ago

Adjuvant Ribociclib and Endocrine Therapy in Patients with HR+/HER2 Negative Early Breast Cancer: Phase III NATALEE Trial

By Dr. Shipra Gandhi from Roswell Park Comprehensive Cancer Center   Findings from the MonarchE clinical trial1 led to the…

2 years ago

Oral SERD Elacestrant is now an option for metastatic hormone-receptor positive breast cancer: Findings from the Phase III EMERALD Trial

By Dr. Shipra Gandhi Roswell Park Comprehensive Cancer Center   Endocrine therapy is the mainstay of the management of hormone…

2 years ago